Market Cap 334.32M
Revenue (ttm) 0.00
Net Income (ttm) -15.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 96,400
Avg Vol 153,542
Day's Range N/A - N/A
Shares Out 13.86M
Stochastic %K 72%
Beta 1.39
Analysts Strong Sell
Price Target $47.50

Company Profile

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States and Romania. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company also develops FLAMINGO-01, which is in Phase III clinical trial designed to evaluate the safety and efficacy...

Industry: Biotechnology
Sector: Healthcare
Phone: 832 819 3232
Address:
Building 14, 3992 Bluebonnet Dr., Stafford, United States
Rolltide2020
Rolltide2020 May. 13 at 12:05 PM
$GLSI i’m predicting cost to borrowto go over 100% today. I could be wrong.
0 · Reply
ATXAMPEREStrategies
ATXAMPEREStrategies May. 13 at 11:43 AM
$GLSI just to put things in perspective….AML market is $3-4B annually. GLSI addressable market is tripple that. ….to give you an idea of the market cap where glsi should be trading.
0 · Reply
WolfSK
WolfSK May. 13 at 9:09 AM
$GLSI so much for not buying any more shares. I couldnt resist. Over 170k shares now. I wasnt the one who bought the 30k on open other day but got plenty in the 22-24 range. We have been going sideways for 6 months. Can see a big move up into a new range as we head into the final straight with the phase 3. GLA
0 · Reply
telomerase
telomerase May. 13 at 12:11 AM
$GLSI SLS is starting to make the idea of an approved peptide vaccine look plausible...
0 · Reply
Rolltide2020
Rolltide2020 May. 13 at 12:02 AM
0 · Reply
alandjoyce
alandjoyce May. 12 at 10:10 PM
$GLSI So glad to see some green here when just about everything else is running red.
0 · Reply
TXcountry
TXcountry May. 12 at 9:40 PM
$GLSI GEMINI-The Wait: Getting to the 14th event (the midway point) requires roughly 1.5 to 2 years of follow-up for a significant portion of the enrollment pool. Since a huge chunk of GLSI's enrollment happened in 2024 and 2025, we are just now entering the "prime window" for those events to occur. Summary The current SOC is so good (85–92% success rate) that "events" (recurrences) are becoming increasingly rare. For a trial like GLSI's, this means the timeline naturally stretches out. If they reach the 14-event interim look and the trial is not stopped for futility, it strongly suggests their drug is keeping pace with or beating the already high bar set by Enhertu and Kadcyla.
0 · Reply
Rolltide2020
Rolltide2020 May. 12 at 8:44 PM
$GLSI Looks like 29 out of 65 active instutional holders still need to report their 13F holdings within the next 3 days. Here's hoping to a continued 8 to 1 ratio of increasing positions vs. decreasing positions.
0 · Reply
HiLowGo
HiLowGo May. 12 at 8:44 PM
$GLSI $SLS Congrats to the SLS longs, may your rainbow shine upon us.
1 · Reply
Waterwing
Waterwing May. 12 at 8:02 PM
0 · Reply
Latest News on GLSI
Greenwich LifeSciences Provides Update on Financing Strategy

Apr 14, 2026, 6:00 AM EDT - 4 weeks ago

Greenwich LifeSciences Provides Update on Financing Strategy


Greenwich LifeSciences adds City of Hope to FLAMINGO-01 trial

2026-03-19T10:12:27.000Z - 7 weeks ago

Greenwich LifeSciences adds City of Hope to FLAMINGO-01 trial


Greenwich LifeSciences Provides Update on Upcoming AACR Meeting

Mar 18, 2026, 6:00 AM EDT - 2 months ago

Greenwich LifeSciences Provides Update on Upcoming AACR Meeting


Greenwich LifeSciences provides update on FLAMINGO-01 trial

2025-12-22T11:15:26.000Z - 5 months ago

Greenwich LifeSciences provides update on FLAMINGO-01 trial


Greenwich LifeSciences Provides Global Update on FLAMINGO-01

Apr 3, 2025, 8:00 AM EDT - 1 year ago

Greenwich LifeSciences Provides Global Update on FLAMINGO-01


Greenwich LifeSciences Partners with GIM in Italy

Nov 26, 2024, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Partners with GIM in Italy


Greenwich LifeSciences Provides Update on Corporate Events

Nov 18, 2024, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Provides Update on Corporate Events


Greenwich LifeSciences Set to Join Russell 2000 Index Again

Jun 26, 2024, 7:33 AM EDT - 2 years ago

Greenwich LifeSciences Set to Join Russell 2000 Index Again


Greenwich LifeSciences Announces $2.5 Million Private Placement

Jun 14, 2024, 6:00 AM EDT - 2 years ago

Greenwich LifeSciences Announces $2.5 Million Private Placement


Rolltide2020
Rolltide2020 May. 13 at 12:05 PM
$GLSI i’m predicting cost to borrowto go over 100% today. I could be wrong.
0 · Reply
ATXAMPEREStrategies
ATXAMPEREStrategies May. 13 at 11:43 AM
$GLSI just to put things in perspective….AML market is $3-4B annually. GLSI addressable market is tripple that. ….to give you an idea of the market cap where glsi should be trading.
0 · Reply
WolfSK
WolfSK May. 13 at 9:09 AM
$GLSI so much for not buying any more shares. I couldnt resist. Over 170k shares now. I wasnt the one who bought the 30k on open other day but got plenty in the 22-24 range. We have been going sideways for 6 months. Can see a big move up into a new range as we head into the final straight with the phase 3. GLA
0 · Reply
telomerase
telomerase May. 13 at 12:11 AM
$GLSI SLS is starting to make the idea of an approved peptide vaccine look plausible...
0 · Reply
Rolltide2020
Rolltide2020 May. 13 at 12:02 AM
0 · Reply
alandjoyce
alandjoyce May. 12 at 10:10 PM
$GLSI So glad to see some green here when just about everything else is running red.
0 · Reply
TXcountry
TXcountry May. 12 at 9:40 PM
$GLSI GEMINI-The Wait: Getting to the 14th event (the midway point) requires roughly 1.5 to 2 years of follow-up for a significant portion of the enrollment pool. Since a huge chunk of GLSI's enrollment happened in 2024 and 2025, we are just now entering the "prime window" for those events to occur. Summary The current SOC is so good (85–92% success rate) that "events" (recurrences) are becoming increasingly rare. For a trial like GLSI's, this means the timeline naturally stretches out. If they reach the 14-event interim look and the trial is not stopped for futility, it strongly suggests their drug is keeping pace with or beating the already high bar set by Enhertu and Kadcyla.
0 · Reply
Rolltide2020
Rolltide2020 May. 12 at 8:44 PM
$GLSI Looks like 29 out of 65 active instutional holders still need to report their 13F holdings within the next 3 days. Here's hoping to a continued 8 to 1 ratio of increasing positions vs. decreasing positions.
0 · Reply
HiLowGo
HiLowGo May. 12 at 8:44 PM
$GLSI $SLS Congrats to the SLS longs, may your rainbow shine upon us.
1 · Reply
Waterwing
Waterwing May. 12 at 8:02 PM
0 · Reply
Daryl1689
Daryl1689 May. 12 at 7:46 PM
$GLSI Dear God, let the 250,000+ shares purchased in the last 36 hours be a sign that an insane run is about to take place. Amen
1 · Reply
Rolltide2020
Rolltide2020 May. 12 at 7:33 PM
$GLSI Unless the purchasing company likes to announce in the afternoon.
0 · Reply
TrailBoss
TrailBoss May. 12 at 7:31 PM
0 · Reply
Lukeing_At_Stocks
Lukeing_At_Stocks May. 12 at 7:30 PM
$GLSI 👀
0 · Reply
werestaying
werestaying May. 12 at 7:18 PM
0 · Reply
HiLowGo
HiLowGo May. 12 at 4:32 PM
$GLSI Every morning I wake up and look to see if there is a PR. GLSI likes to release them early. At least they are consistent. I guess they could break the trend.
1 · Reply
WolfSK
WolfSK May. 12 at 3:24 PM
$GLSI patiently waiting here for news regarding enrolment completion in Phase 3. Expect us to be trading in the $40-50 range post that news. Not long now….. GLA
1 · Reply
Rolltide2020
Rolltide2020 May. 12 at 3:15 PM
$GLSI I had never thought to have Chat analyze a video before. I uploaded a 2 minute clip from the Noble Conference in December and got this take from Chat (FWIW): I reviewed the video. Since it’s a recording of a screen playing an interview, the visual detail is somewhat limited, but there are still a few observable communication/body-language signals from the GLSI CEO (Snehal Patel): He appears composed and controlled throughout the interview rather than defensive or visibly stressed. His posture is generally upright and steady, which typically projects confidence and preparedness. There are multiple moments where he gestures with his hands while speaking, especially when emphasizing points. That usually indicates engagement and comfort with the topic rather than guardedness. I did not see obvious signs commonly associated with discomfort during questioning — such as excessive fidgeting, avoiding eye contact, abrupt posture shifts, or visible agitation.
1 · Reply
navywildcat
navywildcat May. 12 at 3:08 PM
0 · Reply
crypto_biotech
crypto_biotech May. 12 at 1:33 PM
$GLSI https://x.com/crypto_biotech/status/2054182242620960855?s=46 Can’t mention insider buys on any other ticker without mentioning G.O.A.T. :
1 · Reply
Rolltide2020
Rolltide2020 May. 12 at 12:53 PM
$GLSI And a CTB of 81.36% (likely heading over 100%). Powder Keg.
1 · Reply
ScotNotTheBot
ScotNotTheBot May. 12 at 12:38 PM
$GLSI Good morning everyone! I didn’t know this group existed. I own a few shares too. Looking forward to reading everyone’s input!
2 · Reply